Trial Profile
Febuxostat-thiopurine combination therapy in patients with moderately severe inflammatory bowel disease (IBD): a pilot study of a novel drug combination that may influence thiopurine bioavailability
Status:
Not yet recruiting
Phase of Trial:
Phase I
Latest Information Update: 16 Jul 2019
Price :
$35
*
At a glance
- Drugs Febuxostat (Primary) ; Mercaptopurine (Primary)
- Indications Inflammatory bowel diseases
- Focus Pharmacodynamics; Pharmacokinetics
- 29 Nov 2012 New trial record